Ketalux - Ketamine Therapy EducationKetalux - Mental Wellness Authority
Education

How Ketamine Treatment Is Delivered

This page describes common administration methods at a high level for educational purposes. It is not a prescription, recommendation, or endorsement of any specific provider or protocol.

Written by: Ira ZootMedical review status: Not yet clinically reviewed.Last updated: May 18, 2026Evidence: Educational overview

This page has been written and edited by the publisher. It has not been reviewed by a licensed clinician.

Intravenous (IV) infusion

Subanesthetic IV ketamine has the most extensive research base for mental health uses. Dosing, infusion duration, monitoring, and integration vary by program. IV delivery allows precise titration but requires medical infrastructure.

Intranasal esketamine (Spravato)

Esketamine is FDA-approved for treatment-resistant depression and is administered in certified healthcare settings under a restricted program. Sessions involve a monitored observation period after dosing.

Intramuscular (IM) injection

Some clinics use IM ketamine. Onset and pharmacokinetics differ from IV. As with other routes, screening, monitoring, and integration are central to responsible programs.

Oral and sublingual lozenges

Some programs use prescribed lozenges, often in combination with virtual or in-person psychological support. Bioavailability is lower and more variable than parenteral routes, which has implications for dosing and safety.

The role of psychological support

Many clinicians emphasize integration: structured therapy and reflection around dosing sessions. Evidence on the most effective forms of integration is still developing, but thoughtful clinical support is widely considered important.

Educational, not prescriptive
Ketalux does not endorse specific clinics, products, or protocols. Discuss any treatment decisions with a qualified clinician who knows your full medical and psychiatric history.
About the author

Publisher and editor of Ketalux, based in Chicago, Illinois. Ira is a ketamine therapy patient, not a clinician. This is editorial review, not medical review: Ira is not a licensed clinician and does not provide diagnosis or medical care. Ketalux does not accept compensation from providers in exchange for favorable editorial coverage, evidence ratings, recommendations, patient referrals, or organic provider ranking. Read the full publisher disclosure →

Educational use only. The content on this page is provided for general educational purposes and does not constitute medical advice, diagnosis, or treatment. Ketamine and related therapies carry risks and are appropriate only under qualified medical supervision. Always consult a licensed healthcare professional about your individual situation. Information may change as research evolves.